QUOTE AND NEWS
DailyFinance  Apr 17  Comment 
MELBOURNE, AUSTRALIA -- (Marketwired) -- 04/17/14 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) advises that an Extraordinary General Meeting of shareholders was held at 10.00 am today (Melbourne time). Shareholders were asked...
SeekingAlpha  Mar 27  Comment 
By IPOdesktop: Based in Alachua, FL, Applied Genetic Technologies (AGTC) scheduled a $50 million IPO on the Nasdaq with a market capitalization of $179 million at a price range midpoint of $14 for Thursday, March 27, 2014. The full IPO calendar...
newratings.com  Mar 26  Comment 
WASHINGTON (dpa-AFX) - Applied Genetic Technologies Corp. said Wednesday that it has priced its initial public offering of 4,166,667 shares of its common stock at a price to the public of $12.00 per share, which is below its previously estimated...
SeekingAlpha  Mar 26  Comment 
By Don Dion: Applied Genetic Technologies Corp (AGTC), a clinical-stage biotechnology firm, developing treatments for severe inherited diseases of the eye, plans to raise $50.0 million in its upcoming IPO. The Alachua, Florida-based firm will...
DailyFinance  Mar 24  Comment 
MELBOURNE, AUSTRALIA -- (Marketwired) -- 03/24/14 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announced today that in compliance with the ASX Continuous Disclosure Rules, the company is pleased to report the execution of a...
StreetInsider.com  Mar 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Genetic+Tech.+%28GENE%29+Enters+Settlement%2C+License+with+Promega+Corp./9309890.html for the full story.
DailyFinance  Mar 7  Comment 
MELBOURNE, AUSTRALIA -- (Marketwired) -- 03/07/14 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) today announced the recent online publication in the journal Applied Health Economics and Health Policy of a study entitled,...
DailyFinance  Feb 24  Comment 
MELBOURNE, AUSTRALIA -- (Marketwired) -- 02/24/14 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to advise that Ms. Alison Mew has confirmed that she will return to full-time work to resume her position as the Company's...
StreetInsider.com  Feb 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Genetic+Technologies+%28GENE%29+Acting+CEO+Tom+Howitt+Steps+Down+as+Alison+Mew+Returns/9206245.html for the full story.
StreetInsider.com  Feb 13  Comment 
Genetic Technologies Limited (Nasdaq: GENE) 54.6% HIGHER; on Wednesday, the company announced that it has received a further ExParte Re-Examination Certificate from the United States Patent and Trademark Office (“USPTO”), this one dated 10...





You may also be interested in articles related to GENETIC TECHNOLOGIES (GENE):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki